Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions. | Front Oncol;13: 1095219, 2023. | MEDLINE

Conteúdo principal 1 Busca 2 Rodapé 3

+A A -A Alto contraste

BVS - MINISTÉRIO DA SAÚDE

Informação e Conhecimento para a Saúde

português

Localizar descritor de assunto Busca Avançada EVID@Easy

Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions.

Merlini, Alessandra; Pavese, Valeria; Manessi, Giulia; Rabino, Martina; Tolomeo, Francesco; Aliberti, Sandra; D'Ambrosio, Lorenzo; Grignani, Giovanni.

Afiliação

Merlini A; Candiolo Cancer Institute, IRCCS-FPO, Turin, Italy.
Pavese V; Department of Oncology, University of Turin, Turin, Italy.
Manessi G; Department of Oncology, University of Turin, Turin, Italy.
Rabino M; Department of Oncology, University of Turin, Turin, Italy.
Tolomeo F; Department of Oncology, University of Turin, Turin, Italy.
Aliberti S; Candiolo Cancer Institute, IRCCS-FPO, Turin, Italy.
D'Ambrosio L; Candiolo Cancer Institute, IRCCS-FPO, Turin, Italy.
Grignani G; Department of Oncology, University of Turin, Turin, Italy.

Front Oncol ; 13: 1095219, 2023.

Article em En | MEDLINE | ID: mdl-36741019

Palavras-chave

cdk inhibitors; cell cycle; cyclin dependent kinases (CDK); sarcoma; target therapy

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article